Literature DB >> 8037291

Mesenteric inflammatory veno-occlusive disease. A seldom recognized cause of intestinal ischemia.

M J Flaherty1, J T Lie, R C Haggitt.   

Abstract

We describe seven patients (three men, four women; ages 27-78) who presented with signs of intestinal ischemia requiring surgical intervention. In each case, the resected colon, small bowel, or both showed striking phlebitis and venulitis affecting veins of the bowel and mesentery and resulting in ischemic injury of the bowel. In each case, this vasculopathy was the only demonstrable cause of ischemia. Arteritis involving the bowel or the mesentery was not found in any patient, and none had clinical evidence or a history of extraintestinal vasculitis. The composition of the inflammatory infiltrate was variable; in four patients, it was predominantly lymphocytic, in two necrotizing and in one lymphocytic/granulomatous. In addition, three patients also had myointimal hyperplasia of the affected mesenteric veins. Six of seven patients recovered uneventfully after surgery, suggesting a self-limited or indolent process, and the seventh died of an unknown cause. We propose the name mesenteric inflammatory veno-occlusive disease (MIVOD) to describe this unusual and previously unrecognized cause of intestinal ischemia. Its etiology is unknown, and MIVOD may represent a precursor of the recently described idiopathic myointimal hyperplasia of mesenteric veins.

Entities:  

Mesh:

Year:  1994        PMID: 8037291     DOI: 10.1097/00000478-199408000-00003

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  17 in total

1.  Asymptomatic chronic intestinal ischemia caused by idiopathic phlebosclerosis of mesenteric vein.

Authors:  Nobuhide Oshitani; Yoshiki Matsumura; Mizuki Kono; Akihiro Tamori; Kazuhide Higuchi; Takayuki Matsumoto; Shuichi Seki; Tetsuo Arakawa
Journal:  Dig Dis Sci       Date:  2002-12       Impact factor: 3.199

2.  Mesenteric inflammatory venoocclusive disease associated with inferior mesenteric artery aneurysm.

Authors:  Ajit Mahapatra; Phillip Kim
Journal:  Dig Dis Sci       Date:  2002-07       Impact factor: 3.199

3.  Mesenteric venulitis: a rare etiology of hematochezia and "colitis" with distinctive colon pathology.

Authors:  Farid Namin; Jiten Patel; Ivan Damjanov; Richard W McCallum
Journal:  Dig Dis Sci       Date:  2007-04-19       Impact factor: 3.199

4.  Anticoagulation therapy dramatically improved severe sigmoiditis with findings resembling inflammatory bowel disease, which was caused by mesenteric venous thrombosis.

Authors:  Yohei Mikami; Takanori Kanai; Eisuke Iwasaki; Makoto Naganuma; Yoshiyuki Yamagishi; Masayuki Shimoda; Katsuyoshi Matsuoka; Tadakazu Hisamatsu; Yasushi Iwao; Haruhiko Ogata; Seishi Nakatsuka; Makio Mukai; Toshifumi Hibi
Journal:  Clin J Gastroenterol       Date:  2012-11-13

Review 5.  Idiopathic myointimal hyperplasia of mesenteric veins.

Authors:  Joseph Platz; Neil Hyman
Journal:  Gastroenterol Hepatol (N Y)       Date:  2012-10

6.  Refractory pancolitis: a novel presentation of idiopathic myointimal hyperplasia of mesenteric veins.

Authors:  Jason Korenblit; Ashlie Burkart; Robert Frankel; Matthew Klinge; Lindam Greenbau; Scott Goldstein; David Kastenberg
Journal:  Gastroenterol Hepatol (N Y)       Date:  2012-10

7.  Primary antiphospholipid syndrome associated with mesenteric inflammatory veno-occlusive disease.

Authors:  A Gül; M Inanç; L Ocal; M Koniçe; O Aral; J T Lie
Journal:  Clin Rheumatol       Date:  1996-03       Impact factor: 2.980

8.  An unusual case of mesenteric ischaemia.

Authors:  L R O Ayres; M Scott; N Shepherd; J Brown
Journal:  Frontline Gastroenterol       Date:  2013-09-18

9.  Intramural mesenteric venulitis. A new cause of intestinal ischaemia.

Authors:  A Corsi; S Ribaldi; M Coletti; C Bosman
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

10.  Acute acalculous cholecystitis induced by mesenteric inflammatory veno-occlusive disease (MIVOD) in systemic lupus erythematosus.

Authors:  Hideaki Bando; Shigeto Kobayashi; Toshiharu Matsumoto; Naoto Tamura; Kenjiro Yamanaka; Chiharu Yamaji; Chiho Takasaki; Yoshinari Takasaki; Hiroshi Hashimoto
Journal:  Clin Rheumatol       Date:  2003-10-21       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.